Endoscopic Ultrasound-guided Transmural Drainage (EUS-TD) is a minimally invasive first-line modality for the management of two types of pancreatic fluid collection (PFC): pancreatic pseudocyst (PP) and walled-off necrosis (WON). EUS-TD has demonstrated a shorter hospital stay and less morbidity compared to surgical cystogastrostomy. Stents delivery systems are available in different materials and trademarks. Their specific outcomes on PFC types have not been described, particularly in a Hispanic population. To evaluate the outcomes and seek for differences in the management of EUS-TD of PP and WON, between different stents materials and trademarks. Observational, descriptive, longitudinal, retrospective cohort study. Data from EUS-guided drainages of PFC cases were obtained from medical records, as corresponding: PFC characteristics, type of stent (metal: Hot-AxxiosTM, NaggiTM, SpaxusTM; plastic: double Pig-Tail), technical success (including time of procedure), clinical success (follow-up: adverse events, further EUS, imaging, possible re-interventions and PFC resolution). Variables were described in mean or median values, according to statistical distribution (Shapiro-Wilk test), and contrasted through follow-up with corresponding hypothesis testing. Analyses were performed using R v3.4.2 (R Foundation for Statistical Computing, Vienna, Austria). From May-2014 to Oct-2017, 42 consecutive cases were collected: 29/42 PP and 13/42 WON. Baseline characteristics are summarized in table 1. 7/29 PP had spontaneous remission, 3/29 PP and 3/13 WON were lost on follow-up. 19/19 PP and 10/10 WON underwent on EUS-guided stent placement, with 100% technical success. Time of procedure per stents was as following: Hot-AxxiosTM 5 (4-6) min, NaggiTM 19 (18-22) min, SpaxusTM 20 (18-22) min, double Pig-Tail 20 (18–22) min (p<0.01). In PP cases, a bleeding episode occurred 48 hours after a Hot-AxxiosTM placement (p=0.58). In WON cases, an obstruction was reported with a Hot-AxxiosTM, and a bleeding episode occurred 48 hours after a NaggiTM placement (p=0.69). Both bleeding events required surgical management. Overall adverse events rate was 10% (3/29) with no reports from plastic stent cases. Overall 30-day mortality was 0% (figure 1). All stents were finally removed. On this series, none of the cases needed percutaneous drainage. Overall median time from stent placement to complete drainage & removal was 8 (1–20) weeks; overall median longest follow-up time was 41 (8–120) weeks. 3 cases (2 SpaxusTM, 1 NaggiTM) cannot be released due to device failure, and no cases of Hot-AxxiosTM or Plastic stent. Neither stent material nor trademark present a significant impact on PFC outcomes, even in the presence of adverse events. Compared to other stents, Hot-AxxiosTM seems to be more practical and faster for placement.Tabled 1Table 1. Baseline characteristics.(n = 42)Age (years), median (range)48 (10 – 76)Gender (female), n (%)19 (46.3)Etiology, n (%)Alcohol11 (26.8)Biliary31 (73.8)Type of PFC, n (%)Pseudocyst (PP)29 (69.0)Walled-off necrosis (WON)13 (31.0)Size of PFC (cm), median (range)7 (1 – 14)Site of PFC, n (%)Head – Body16 (38.0)Body – Tail26 (62.0)Indication for drainage, n (%)Pain30 (71.0)Infection12 (29.0)Concurrent ERCP for PFC approach, n (%)5 (11.9)PFC in remission during diagnosis, n (%)7 (16.7)Patients not attempted & lost follow-up, n (%)6 (14.2)Patients addressed to EUS-guided drainage, n (%)29 (69.0)Metal stent delivery system, n (%)25/29 (86.2)Metal stents delivery system, by Trademark, n (%)Hot-AxxiosTM9/25 (36.0)NaggiTM10/25 (40.0)SpaxusTM6/25 (24.0)Plastic stent delivery system, n (%)Pig-Tail4/29 (13.8) Open table in a new tab